COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 2234: Articles 22331-22340  | Next

Alternative or Complementary Role of Serological Rapid Antibody Test in the Management of Possible COVID-19 Cases
Yildirim, F., Yildiz Gulhan, P., Diken, O. E., Capraz, A., Simsek, M., Botan Yildirim, B., Taysi, M. R., Yilmaz Ozturk, S., Demirtas, N., Ergil, J., Dirican, A., Uzar, T., Karaman, I., OZKAYA, S.
10.1101/2020.09.13.20193615 — Posted: 2020-09-14
Secondary traumatic stress and burnout in healthcare workers during COVID-19 outbreak
Marzetti, F., Vagheggini, G., Conversano, C., Miccoli, M., Gemignani, A., Ciacchini, R., Panait, E., Orru, G.
10.1101/2020.09.13.20186692 — Posted: 2020-09-14
The impact of digital contact tracing on the SARS-CoV-2 pandemic - a comprehensive modelling study
Pollmann, T. R., Pollmann, J., Wiesinger, C., Haack, C., Shtembari, L., Turcati, A., Neumair, B., Meighen-Berger, S., Zattera, G., Neumair, M., Apel, U., Okolie, A., Mueller, J., Schoenert, S., Resconi, E.
10.1101/2020.09.13.20192682 — Posted: 2020-09-14
Mental health service activity during COVID-19 lockdown among individuals with Personality Disorders: South London and Maudsley data on services and mortality from January to May 2020
Nuzum, E., Martin, E., Broadbent, M., Stewart, R.
10.1101/2020.09.13.20193730 — Posted: 2020-09-14
The impact of natural disasters on the spread of COVID-19: a geospatial, agent based epidemiology model
Van Wyk de Vries, M. S., Rambabu, L.
10.1101/2020.09.12.20193433 — Posted: 2020-09-14
A full-scale agent-based model of Lombardy COVID-19 dynamics to explore social networks connectivity and vaccine impact on epidemic
Giacopelli, G.
10.1101/2020.09.13.20193599 — Posted: 2020-09-14
Role of Weather Factors in COVID-19 Deaths in Tropical Climate: A Data-Driven Study Focused on Brazil
Kalippurayil Moozhipurath, R.
10.1101/2020.09.13.20193532 — Posted: 2020-09-14
Clinical characteristics and outcomes of patients with COVID-19 and ARDS admitted to a third level health institution in Mexico City
LUGO GOYTIA, G., Hernandez-Cardenas,, C., Torruco-Sotelo, C., Jurado, F., Serna-secundino, H., Aguilar, C., Garcia-Olanzaran, J., Hernandez-Garcia, D.
10.1101/2020.09.12.20193409 — Posted: 2020-09-14
Analysis of the interventions adopted due to the COVID-19 on ARI morbility for Colombia
Quijano-Angarita, A., Espinosa, O., Mercado-Reyes, M. M., Walteros, D., Malo, D. C.
10.1101/2020.09.12.20193334 — Posted: 2020-09-14
Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles
Lusczek, E. R., Ingraham, N. E., Karam, B., Proper, J., Siegel, L., Helgeson, E., Lotfi-Emran, S., Zolfaghari, E. J., Jones, E., Usher, M., Chipman, J., Dudley, R. A., Benson, B., Melton, G. B., Charles, A., Lupei, M. I., Tignanelli, C. J.
10.1101/2020.09.12.20193391 — Posted: 2020-09-14 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).